BioNTech
BNTX
BNTX
285 hedge funds and large institutions have $3.3B invested in BioNTech in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 86 increasing their positions, 99 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 287 → 285 (-2)
13% less capital invested
Capital invested by funds: $3.78B → $3.3B (-$488M)
13% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 99
Holders
285
Holding in Top 10
6
Calls
$145M
Puts
$137M
Top Buyers
| 1 | +$83.2M | |
| 2 | +$67.9M | |
| 3 | +$42.6M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$38.3M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$37.4M |
Top Sellers
| 1 | -$148M | |
| 2 | -$81.5M | |
| 3 | -$37.7M | |
| 4 |
ClearBridge Investments
New York
|
-$33.4M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$30.1M |